Skip to Content
Merck

MAB9013

Anti-Coronavirus Group Antigen Antibody, nucleoprotein of OC-43, clone 542-7D

clone 542-7D, Chemicon®, from mouse

Sign In to View Organizational & Contract Pricing.

Select a Size



About This Item

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702

Product Name

Anti-Coronavirus Group Antigen Antibody, nucleoprotein of OC-43, clone 542-7D, clone 542-7D, Chemicon®, from mouse

biological source

mouse

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

542-7D, monoclonal

species reactivity

human

manufacturer/tradename

Chemicon®

technique(s)

immunofluorescence: suitable

isotype

IgG

shipped in

wet ice

Quality Level

Application

Anti-Coronavirus Group Antigen Antibody, nucleoprotein of OC-43, clone 542-7D detects level of Coronavirus Group Antigen & has been published & validated for use in IF.
IFA. Final working dilutions must be determined by end user.
Research Category
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral

Biochem/physiol Actions

Coronavirus nucleoprotein; Strain OC-43

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Immunogen

Epitope: nucleoprotein of OC-43.

Physical form

Format: Purified
Purified Immunoglobulin. Supplied in PBS buffer pH 7.4. Contains 0.1% sodium azide and carrier protein.

Preparation Note

Maintain at +4°C for up to 12 months. Avoid repeated freeze/thaw cycles.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Not finding the right product?  

Try our Product Selector Tool.

Storage Class

12 - Non Combustible Liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Ryohei Hirose et al.
mSphere, 6(3) (2021-05-14)
Human coronavirus (HCoV)-OC43 rarely shows a cytopathic effect (CPE) after infection of various cell lines, and the indirect immunoperoxidase assay (IPA), a relatively complex procedure, has long been used as an alternative assay. Because HCoV-OC43 uses cell-surface transmembrane protease serine
Sarah E Philo et al.
The Science of the total environment, 760, 144215-144215 (2020-12-20)
Wastewater1 surveillance of SARS-CoV-2 may be a useful supplement to clinical surveillance as it is shed in feces, there are many asymptomatic cases, and diagnostic testing can have capacity limitations and extended time to results. Although numerous studies have utilized
Gergely Rona et al.
Cell death and differentiation, 29(2), 285-292 (2021-12-05)
The risk of zoonotic coronavirus spillover into the human population, as highlighted by the SARS-CoV-2 pandemic, demands the development of pan-coronavirus antivirals. The efficacy of existing antiviral ribonucleoside/ribonucleotide analogs, such as remdesivir, is decreased by the viral proofreading exonuclease NSP14-NSP10
Daniel Poston et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(5), e1208-e1211 (2020-12-04)
Cross-reactive immune responses elicited by seasonal coronaviruses might affect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) susceptibility and disease outcomes. We measured neutralizing activity against SARS-CoV-2 in prepandemic sera from patients with prior polymerase chain reaction scan-confirmed seasonal coronavirus infection.
Kentaro Uemura et al.
iScience, 24(10), 103120-103120 (2021-09-21)
Newly emerging or re-emerging viral infections continue to cause significant morbidity and mortality every year worldwide, resulting in serious effects on both health and the global economy. Despite significant drug discovery research against dengue viruses (DENVs) and severe acute respiratory

Global Trade Item Number

SKUGTIN
MAB901304053252617348

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service